Table 1.

Patient characteristics and KLF4 expression

CharacteristicTotal (n = 86)KLF4 stainingP
Negative (%), n = 27Weak (%), n = 47Strong (%), n = 12
Sex
    Men5620 (35.7)29 (51.7)7 (12.5)0.487
    Women307 (23.3)18 (60.0)5 (16.7)
Age (years)
    Mean (SD)61.8 (14.0)57.4 (15.0)62.6 (13.5)68.4 (11.3)0.463
Pathology type
    Papillary121 (8.3)9 (75.0)2 (16.7)0.358
    Tubular287 (25.0)15 (53.6)6 (21.4)
    Diffuse82 (25.0)4 (50.0)2 (25.0)
    Mucinous52 (40.0)2 (40.0)1 (20.0)
    Signet ring219 (42.9)11 (52.3)1 (4.8)
    Mixed126 (50.0)6 (50.0)0 (0.0)
Stage
    I140 (0.0)12 (85.7)2 (14.3)0.005
    II285 (17.9)17 (60.7)6 (21.4)
    III3015 (50.0)11 (36.7)4 (13.3)
    IV147 (50.0)7 (50.0)0 (0.0)
Residual disease
    R06916 (23.2)41 (59.4)12 (17.4)0.003
    R1, R21711 (64.7)6 (35.3)0 (0.0)
Lauren's classification
    Intestinal5314 (26.4)30 (56.6)9 (16.9)0.351
    Diffuse3313 (39.4)17 (51.5)3 (9.1)
  • NOTE: Pearson's χ2 test was done to determine the statistical significance of the relationship of KLF4 expression with various variables.